Signs of STD

Adults have sex at every age, so it follows that STDs can spread at every age. But my older patients who have new sexual partners are sometimes bewildered when I ask if they want to get screened. It's healthy to be sexually active as an older adult, and it correlates with greater enjoyment of life. My patients tell me that nursing homes can present really exciting opportunities to make new friends in this regard. About 40 percent of adults ages 65-80 are sexually active, and about 10 percent of people older than 90 are sexually active, though it bears noting that the latter figure is based on a survey limited to one municipality in Sweden. But STDs spare no one. Few people I've seen whose STD testing comes back positive were expecting that result. And from 2007 to 2017, STD cases more than doubled among adults among adults 65 and older. That is why it is important to get screened and always use a condom. Condoms are infrequently utilized among older people, but they do reduce,

2. Chlamydia Is Caused by Sexually Transmitted Bacteria  The bacteria  Chlamydia trachomatis  causes chlamydia infection, which usually occurs in the genital tract, so the cervix in women and the penis in men. In both women and men, the bacteria may also infect the rectum and the throat. "Infections are spread during any kind of sexual activity: vaginal, anal, or oral intercourse," says Jonathan Schaffir, MD, clinical professor of obstetrics and gynecology at Ohio State University Wexner Medical Center in Columbus. Chlamydia trachomatis can also cause conjunctivitis (pink eye) if the bacteria come into contact with the eyelids or the clear membrane covering the white of the eye. Because chlamydia infections often cause no symptoms, individuals who have one may not seek medical attention or get treated for it. However, anyone who is infected with chlamydia can pass it to other people, who can, in turn, pass it to others. 3. Young Sexually A

Overview Gonorrhoea is a sexually transmitted infection (STI) that remains a major public health concern. WHO estimates that in 2020, there were 82.4 million [47.7 million-130.4 million] new cases infected among adolescents and adults aged 15–49 years worldwide, with a global incident rate of 19 (11–29) per 1000 women and 23 (10–43) per 1000 men. Most cases were in the WHO African Region and the Western Pacific Region. Antimicrobial resistance (AMR) in Neisseria gonorrhoeae ( N. gonorrhoeae ) appeared soon after the antimicrobial medicines started to be used. This has continued to expand over the past 80 years, affecting medicines such as tetracyclines, macrolides (including azithromycin), sulphonamides and trimethoprim combinations and, more recently, quinolones. In many countries, ciprofloxacin resistance is exceedingly high, azithromycin resistance is increasing and resistance or decreased susceptibility to cefixime and ceftriaxone continue to emerge. The extensively dr

Distributed via the CDC Health Alert Network March 28, 2024, 1:30 PM ET CDCHAN-00505 Summary The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to alert healthcare providers to an increase in invasive meningococcal disease, mainly attributable to Neisseria meningitidis serogroup Y (Figure). In 2023, 422 cases were reported in the United States, the highest annual number of cases reported since 2014. As of March 25, 2024, 143 cases have been reported to CDC for the current calendar year, an increase of 62 cases over the 81 reported as of this date in 2023. A specific meningococcal strain, sequence type (ST) 1466, is responsible for most (101 of 148, 68%) serogroup Y cases with available sequence type data that were reported across the United States in 2023. Cases caused by this strain are disproportionately occurring in people ages 30–60 years (65%), Black or African American people (63%), and people with HIV (15%). In addi

The City of Austin (City) seeks proposals in response to this Request for Proposals (RFP) from qualified social service providers (Offerors) with demonstrated experience in providing all of the following HIV and STI services: testing for HIV, chlamydia, gonorrhea, syphilis, and hepatitis C;low cost or free walk-in testing for new and existing patients; mobile testing, low-cost or free same day STI treatment; HIV medical care and treatment; and PrEP access.  RFP INFORMATION DATE ISSUED: Monday, January 22, 2024 INTENT TO APPLY DUE DATE: Monday, February 5, 2024, 3 PM CST RFP PROPOSAL DUE DATE: Tuesday, February 20, 2024, 3 PM CST Anticipated Start date of contract: Wednesday, May 15, 2024 Questions regarding the RFP are due on or before: Tuesday, February 13, 2024, 3 PM CST Technical Assistance regarding submission of the RFP in PartnerGrants are due on or before: Thursday, Febr

A study of more than 50 babies through age 2 in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days — rather than within weeks or months — of life can safely suppress amounts of HIV in the blood to undetectable levels. Findings of the study, which was co-led by Johns Hopkins Children's Center physician-scientist and researcher Deborah Persaud, M.D., and sponsored by the National Institutes of Health (NIH) and the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, were published Dec. 4 in the journal The Lancet HIV . HIV (human immunodeficiency virus) attacks the immune system. There is no cure for the disease caused by HIV, however, ART can help control the virus and prevent it from progressing to AIDS, the most severe and potentially lethal stage of HIV infection. A pregnant person with HIV who is not receiving ART has a 15% to 45% chance of tr

Content From : HIV.gov • Updated : March 22, 2024 • 8 min read Topics PrEP Pre-Exposure Prophylaxis Prevention What is PrEP? PrEP, or pre-exposure prophylaxis, is medicine people at risk for HIV take to prevent getting HIV from sex or injection drug use. PrEP can stop HIV from taking hold and spreading throughout your body. Currently, there are two FDA-approved daily oral medications for PrEP. A long-acting injectable form of PrEP has also been approved by the FDA. Why Take PrEP? PrEP is highly effective at preventing HIV when taken as indicated. PrEP reduces the risk of getting HIV from sex by about 99% when taken as prescribed. Among people who inject drugs, it reduces the risk by at least 74% when taken as prescribed. PrEP is much less effective when it isn't taken consistently. Is PrEP Right for You? PrEP may benefit you if you test negative for HIV and any of the following apply to you: you have had anal or vaginal sex in the past 6 months , and you: have a sexual partner wi